Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, ...

For patients with lung cancer, advancements such as robotic surgery and video-assisted thoracic surgery have dramatically ...

The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue ...

Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally ...

For patients with bladder cancer undergoing radical cystectomy, or the surgical removal of the bladder, one possible option ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...

A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life ...

Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful ...

Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood ...

Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr.

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or ...

The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...